| Affiliation: | 1. Nuclear Medicine Unit, Fondazione Salvatore Maugeri, Pavia, Italy;2. Pathology and Cytology Unit, Policlinico San Donato, San Donato Milanese, Milano, Italy;3. Oncology Unit, Fondazione Salvatore Maugeri, Pavia, Italy;4. Department of Urology, Azienda Ospedaliera della Provincia di Pavia, Voghera, Italy;5. Radiation Oncology Unit, Fondazione Salvatore Maugeri, Pavia, Italy;1. Department of Urology, St. Elisabeth Klinikum Straubing, Straubing, Germany;2. Department of Urology, Vivantes Kliniken Am Urban und Im Friedrichshain Berlin, Berlin, Germany;3. Department of Urology, Vivantes Kliniken AVK Berlin, Berlin, Germany;4. Department of Urology, University of Regensburg, Caritas-St. Josef Medical Center, Regensburg, Germany;5. Department of Urology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany;1. Department of Urology and Radiology, Icahn School of Medicine at Mount Sinai, New York, New York;2. Department of Radiology, North Shore-Long Island Jewish Hofstra School of Medicine, New Hyde Park, New York;3. Department of Pathology, North Shore-Long Island Jewish Hofstra School of Medicine, New Hyde Park, New York;4. Urologic Oncology Branch, National Institutes of Health, Bethesda, Maryland;5. Biometric Research Branch, National Institutes of Health, Bethesda, Maryland;6. Molecular Imaging Program, National Institutes of Health, Bethesda, Maryland;7. Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland;8. Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;1. Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand;2. Department of Ophthalmology, Auckland City Hospital, Auckland, New Zealand;1. Truven Health Analytics, Inc, Bethesda, Maryland;2. Janssen Pharmaceuticals, LLC, Horsham, Pennsylvania |
